Cheng Yi Pharmaceutical Celebrates its 50th Anniversary with Sincerity to Build a Centennial Brand

On October 19, 2016, Zhejiang Cheng Yi Pharmaceutical Co., Ltd. celebrated its 50th anniversary, starting from a small workshop with only two water tanks and a few feet of fine cloth, and now becoming one of the top 500 pharmaceutical legal entities in China. We continue to adhere to the entrepreneurial spirit of diligence, rigor, innovation, and dedication, and build a century old brand legend.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. is currently a comprehensive modern professional pharmaceutical enterprise specializing in the production of various preparations, APIs and pharmaceutical intermediates. It is also a national key high-tech enterprise, a national contract abiding and trustworthy unit, a provincial, municipal and district key backbone enterprise, and a leading enterprise of local private enterprises in Dongtou District; The enterprise can produce over 60 varieties and nearly a hundred specifications of drugs, all of which have passed national GMP certification. Several products have passed GMP certification in multiple countries and regions such as the US FDA, Australia TGA, and the EU EMEA. The products are sold to various provinces and cities in China, as well as more than 30 countries and regions abroad.

In 2015, the company's sales revenue was 350 million yuan, with a profit of 78 million yuan and a tax payment of 52 million yuan. The completion of various indicators in the first three quarters of 2016 was good, and the company's listing work has entered the feedback stage of application materials. It is expected to be listed on the main board of the Shanghai Stock Exchange in the first half of next year.

It is understood that this celebration event includes the Zhejiang Marine Biomedical Forum and celebration conference, as well as a condolence performance. At that time, Yang Huanming, academician of the Chinese Academy of Sciences, Tao Jianhong, editor in chief of the Pharmaceutical Economy News, and others will make wonderful reports on gene and Drug design, analysis of drug economy development trend, and other contents.